← All trials

NCT04551222

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Feb 1, 2021
Primary completion
May 30, 2025
Completion date
Nov 3, 2025
First posted
Sep 16, 2020
Last posted
Nov 16, 2020
Enrollment
120
Arms / groups
2 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.